MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHLEGEL, H. B.
Right arrow Articles by HOOGSTEEN, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHLEGEL, H. B.
Right arrow Articles by HOOGSTEEN, K.

Molecular Pharmacology, Vol 20, 154-158, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Models for the Binding of Methotrexate to Escherichia coli Dihydrofolate Reductase

Direct Effect of Carboxylate of Aspartic Acid 27 upon Ultraviolet Spectrum of Methotrexate

H. BERNHARD SCHLEGEL 1, MARTIN POE 1, and KARST HOOGSTEEN 1

1 Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065

Ab initio molecular orbital calculations were performed on neutral and protonated 2,4-diamino-6-methylpteridine. The computations were repeated for the N-1-protonated molecule in a highly simplified model of the methotrexate binding site of Escherichia coli dihydrofolate reductase. The strengths of the ionic bond to Asp 27, the hydrogen bond to Thr 113, and the interaction with the peptide bonds between Ile 5 and Ala 6 and between Ala 6 and Ala 7 were calculated to be 100, 10, 5, and 1 kcal/mole, respectively, in the absence of solvent. These strengths suggest that the ionic bond is the most important component of the binding of protonated methotrexate. The energy calculations also provide a semiquantitative explanation of the hitherto unexplained shift to longer wavelength of the lowest-frequency UV absorbance band of N-1-protonated methotrexate upon binding to dihydrofolate reductase. This shift is due to a direct effect of the electrostatic field of the carboxylate ion of Asp 27 upon the molecular orbitals of the methotrexate.

Submitted on October 23, 1980
Accepted on March 30, 1981




This article has been cited by other articles:


Home page
ScienceHome page
E. Howell, J. Villafranca, M. Warren, S. Oatley, and J Kraut
Functional role of aspartic acid-27 in dihydrofolate reductase revealed by mutagenesis
Science, March 7, 1986; 231(4742): 1123 - 1128.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics